Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 through a demerger from SUN PHARMA, a global leader in speciality generics. We strive to build an enduring innovation engine built on strong scientific execution, high value analytics and aggressive portfolio management.
A robust mix of internal ideation and strategic partnering with academic innovators and bio-pharma entrepreneurs fuel our engine with potentially high impact ideas. We partner with thought-leading clinicians across the world for ideas and access. Innovation through integration of partner knowledge and efficient internal execution shapes our future.
"Attn. Shareholders holding shares in Physical Form!!!
Kindly note that consequent to amendment to regulation 40 of SEBI (LODR) Regulations, 2015 ( vide SEBI (LODR) (Fourth Amendment) Regulations, 2018), the Company shall not accept any request for transfer of shares, which are held in physical form, with effect from 5th December 2018. You are therefore advised to dematerialize all your shareholding with any of the Depositories at the earliest."